Combination of ankylosing spondylitis with combined autoinflammatory skin lesions. Clinical case and review
Abstract
A clinical case of a patient with axial spondyloarthritis (AxSpA) and chronic recurrent skin lesions in the form of acne conglobata, suppurative hydradenitis and the formation of fistulous tracts is presented. On the example of clinical observation, a diagnostic search was described, which included suppurative hydradenitis, SAPHO syndrome: synovitis, acne, pustulosis, hyperostosis, PASS syndrome: pyoderma gangrenosum, acne, ankylosing spondylitis, suppurative hydradenitis and the selection of therapy is argued. The possibilities of using biologic drugs in patients with AxSpA and concomitant autoinflammatory skin processes are described.
About the Authors
D. A. Dibrov
V.A. Nasonova Research Institute of Rheumatology
Russian Federation
Russian Federation
Danil Alekseevich Dibrov
34A, Kashirskoe Shosse, Moscow 115522
T. V. Korotaeva
V.A. Nasonova Research Institute of Rheumatology
Russian Federation
Russian Federation
34A, Kashirskoe Shosse, Moscow 115522
S. O. Krasnenko
V.A. Nasonova Research Institute of Rheumatology
Russian Federation
Russian Federation
34A, Kashirskoe Shosse, Moscow 115522
M. M. Urumova
V.A. Nasonova Research Institute of Rheumatology
Russian Federation
Russian Federation
34A, Kashirskoe Shosse, Moscow 115522
L. S. Kruglova
Central State Medical Academy of Administrative Department of the President of the Russian Federation
Russian Federation
Russian Federation
121359, Moscow, Marshal Tymoshenko str., 19, build. 1a
A. M. Lila
V.A. Nasonova Research Institute of Rheumatology; Russian Medical Academy of Continuing Professional Education
Russian Federation
Russian Federation
34A, Kashirskoe Shosse, Moscow 115522;
2/1, Barrikadnaya St., Build. 1., Moscow 125993
References
1. Erdes SF, Badokin VV, Bochkova AG, et al. ON THE TERMINOLOGY OF SPONDYLOARTHRITIS. Rheumatology Science and Practice. 2015;53(6):657-660. doi: 10.14412/1995-4484-2015-657-660 (In Russ.).
2. Avalos-Diaz E, Dominguez-Cherit J, Herrera-Esparza R. Cutaneous manifestations of spondyloarthritis. Int J Clin Rheumatol. 2012 Feb;7(1):55–61. doi: 10.2217/IJR.11.64.
3. Acquacalda E, Roux CH, Albert C et al. New onset of articular inflammatory manifestations in patients with hidradenitis suppurativa under treatment with infliximab. Joint Bone Spine. 2015 Oct;82(5):362-4. doi: 10.1016/j.jbspin.2015.01.020.
4. Fauconier M, Reguiai Z, Barbe C, et al. Association between hidradenitis suppurativa and spondyloarthritis. Joint Bone Spine. 2018 Oct;85(5):593-597. doi: 10.1016/j.jbspin.2017.09.005.
5. Lee J H, Kwon H S, Jung H M, et al. Prevalence and comorbidities associated with hidradenitis suppurativa in Korea: A nationwide population-based study. J Eur Acad Dermatol Venereol. 2018 Oct;32(10):1784-1790. doi: 10.1111/jdv.15071.
6. Vossen ARJV, van der Zee HH, Prens EP. Hidradenitis Suppurativa: A Systematic Review Integrating Inflammatory Pathways Into a Cohesive Pathogenic Model. Front Immunol. 2018 Dec 14;9:2965. doi: 10.3389/fimmu.2018.02965.
7. Zouboulis, C, Desai N, Erntestam L et al. European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa. J Eur Acad Dermatol Venereol. 2015 Apr;29(4):619-44. doi: 10.1111/jdv.12966.
8. Calderón-Castrat X, Bancalari-Diaz D, Román-Curto C et al. PSTPIP1 Gene mutation in a pyoderma gangrenosum, acne and suppurative hidradenitis (PASH) Syndrome. Br J Dermatol, 2015. 2016 Jul;175(1):194-8. doi: 10.1111/bjd.14383.
9. Starnes T, Bennin D, Bing X et al. The F-BAR protein PSTPIP1 controls extracellular matrix degradation and filopodia formation in macrophages. Blood, 2014 Apr 24;123(17):2703-14. doi: 10.1182/blood-2013-07-516948.
10. Strowig T, Henao-Mejia J, Elinav E, Flavell R. Inflammasomes in health and disease. Nature, 2012 Jan;481(7381):278-86. doi: 10.1038/nature10759.
11. Vinkel C, Thomsen S F. Autoinflammatory syndromes associated with hidradenitis suppurativa and/or acne, Int J Dermatol. 2017 Aug;56(8):811-818. doi: 10.1111/ijd.13603.
12. Gottlieb J, Madrange M, Gardair C et al. PAPASH, PsAPASH and PASS autoinflammatory syndromes: phenotypic heterogeneity, common biological signature and response to immunosuppressive regimens. Br J Dermatol. 2019 Oct;181(4):866-869. doi: 10.1111/bjd.18003.
13. Leuenberger M, Berner J, Di Lucca J, et al. PASS Syndrome: An IL-1-Driven Autoinflammatory Disease. Dermatology. 2016 Feb;232(2):254-258. doi:10.1159/000443648.
14. Badokin VV. SAPHO syndrome. Rheumatology Science and Practice. 2004;42(3);61-65 (In Russ.).
15. Zimmermann P, Curtis N. Synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome – A challenging diagnosis not to be missed. 2016 Jul;72 Suppl:S106-14. doi: 10.1016/j.jinf.2016.04.030.
16. Liu S, Tang M, Cao Y, Li C. Synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome: review and update. Ther Adv Musculoskelet Dis. 2020 May 12;12:1759720X20912865. doi: 10.1177/1759720X20912865.
17. Rozin A P. SAPHO syndrome: is a range of pathogen-associated rheumatic diseases extended? Arthritis Res Ther. 2009 Nov;11(6):131. doi: 10.1186/ar2837.
18. Firinu D, Barca MP, Lorrai MM, et al. TH17 cells are increased in the peripheral blood of patients with SAPHO syndrome. Autoimmunity. 2014 Sep;47(6):389-94. doi: 10.3109/08916934.2014.906582.
19. Vekic DA, Woods J, Lin P, Cains GD. SAPHO syndrome associated with hidradenitis suppurativa and pyoderma gangrenosum successfully treated with adalimumab and methotrexate: A case report and review of the literature. Int J Dermatol. 2018 Jan;57(1):10-18. doi:10.1111/ijd.13740
20. Daoussis D, Konstantopoulou G, Kraniotis P et al. Biologics in SAPHO syndrome: A systematic review. Semin Arthritis Rheum. 2019 Feb;48(4):618-625. doi: 10.1016/j.semarthrit.2018.04.003.
Review
For citations:
Dibrov DA, Korotaeva TV, Krasnenko SO, Urumova MM, Kruglova LS, Lila AM. Combination of ankylosing spondylitis with combined autoinflammatory skin lesions. Clinical case and review. Sovremennaya Revmatologiya=Modern Rheumatology Journal. (In Russ.)
Views:
1525
Email this article 